Featured Research

from universities, journals, and other organizations

Statins Reduce Levels Of Protein Linked To Inflammation, Heart Attack And Stroke

Date:
April 23, 2001
Source:
American Heart Association
Summary:
New research shows that three major statin drugs have similar anti-inflammatory effects, a key factor in atherosclerosis, according to a study in Circulation: Journal of the American Heart Association.

DALLAS, April 17 – New research shows that three major statin drugs have similar anti-inflammatory effects, a key factor in atherosclerosis, according to a study in today’s Circulation: Journal of the American Heart Association.

Statin drugs lower cholesterol and previous research indicated that the statin – pravastatin – could reduce blood levels of C-reactive protein (CRP), a protein associated with the severe arterial inflammation that leads to heart attacks and strokes. New research finds that other statins – simvastatin and atorvastatin – can also reduce CRP.

"This is the first study where all three statin drugs were used in the same patients and their results compared," says Ishwarlal Jialal, M.D., Ph.D., director of the division of clinical biochemistry and human metabolism at the University of Texas Southwestern Medical Center at Dallas. "We found that 70 percent to 80 percent of patients who took any of these statins lowered their CRP to below 2.0 milligrams per liter, the critical level at which the risk of heart attack or stroke increases dramatically."

The randomized, double-blind study involved 22 individuals, average age 48, with elevated LDL or "bad" cholesterol and high triglyercides. Subjects followed the American Heart Association Step 1 diet (low-fat) and were given the three drugs alternately for periods of six weeks. Blood samples were taken three times at the beginning of the study and twice after each six-week period.

The CRP levels were reduced in 73 percent of subjects while taking pravastatin and 82 percent while taking simvastatin or atorvastatin. The average CRP reductions were 20 percent, 23 percent and 28 percent respectively.

CRP is known to be a major marker for any type of inflammation in the body, including pneumonia, tonsillitis and arthritis. There is evidence that elevated CRP also may be an independent risk factor for the arterial inflammation of atherosclerosis.

Jialal notes that CRP levels of less than 10 milligrams per liter (mg/L) are considered "normal" by present medical standards. "Yet several studies have shown that, in order to achieve a very low risk of cardiovascular disease, the CRP level must be below 0.7 mg/L," he says. "At levels of just 2.0 mg/L or above, the risk doubles or triples using the high sensitive assay which is now available in most academic medical centers.

"The good thing about all three statin drugs is that they lower CRP at the same time that they lower LDL and triglycerides," Jialal concludes. "This is probably why they are associated with lower mortality from heart attacks and strokes."

This study for the first time shows that there is a significant correlation between reduction in CRP and triglyceride levels. There is no correlation between reducing LDL cholesterol and reducing CRP, Jialal emphasizes. A person with normal LDL may still be at risk from elevated CRP and vice-versa.

Researchers explored the mechanism for the reduction in CRP with statins by measuring the main stimulus for CRP production in the liver, the pro-inflammatory agent, interleukin-6. But results showed that interleukin-6 levels were not significantly reduced by any of the drugs.

Jialal acknowledges that because of the study’s small sample size, these findings should be viewed with caution and further study is needed.

Other researchers include Daniel Stein, M.D.; David Balis, M.D.; Scott Grundy, M.D., Ph.D.; Beverly Adams-Huet, M.S.; and Sridevi Devaraj, Ph.D.

The research was funded in part by the National Institutes of Health.


Story Source:

The above story is based on materials provided by American Heart Association. Note: Materials may be edited for content and length.


Cite This Page:

American Heart Association. "Statins Reduce Levels Of Protein Linked To Inflammation, Heart Attack And Stroke." ScienceDaily. ScienceDaily, 23 April 2001. <www.sciencedaily.com/releases/2001/04/010417075725.htm>.
American Heart Association. (2001, April 23). Statins Reduce Levels Of Protein Linked To Inflammation, Heart Attack And Stroke. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2001/04/010417075725.htm
American Heart Association. "Statins Reduce Levels Of Protein Linked To Inflammation, Heart Attack And Stroke." ScienceDaily. www.sciencedaily.com/releases/2001/04/010417075725.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins